InvestorsHub Logo

ExtremelyBullishZig

12/15/20 8:31 AM

#287740 RE: biotechnician #287738

Why not...two more trials to go...9 to 12 months to revenue...more dilution needed to keep those trials going and maintain 2 years operating expenses in the bank.

Smart people sold on the 7's and 8's and are already increasing their share counts before the market opens.

Turner2017

12/15/20 8:34 AM

#287744 RE: biotechnician #287738

Based on the results in this first of its kind U.S. Phase 2 (ANAVEX®2-73-RS-001)2 study in adult patients with Rett syndrome, Anavex is planning to meet with FDA to discuss the approval pathway. There are no FDA-approved drugs for Rett syndrome. ANAVEX®2-73 has Fast Track designation, Rare Pediatric Disease designation and Orphan Drug designation from the FDA for the treatment of Rett syndrome and may be considered for accelerated approval.

Cbdpotential

12/15/20 8:59 AM

#287770 RE: biotechnician #287738

I thought I was a hoarder... now I’m beginning to THINK I’m “a genius” and can’t wait to buy more long term storage units ;-)
Sell!? Thats like watching a soccer match that’s 0-0 for generations and then when a team scores for the first time in history! one decides to leave the arena? I understand there’s some PTSD here from past scientific achievements going unrecognized but, I believe it’s important for one, more than ever, to focus on the long term - step back and see the big picture here again before acting.
Proof of concept just broke the surface.
As long as the science continues .. I’ll be a shareholder till I die ... and setting up a trust for beyond. ;-)